Coronavirus disease 2019 (COVID-19) remains a threat with the emergence of new variants,
especially Delta and Omicron, without specific effective therapeutic drugs. The infection …

Background Coinfections with respiratory viruses among SARS CoV-2 patients have been
reported by several studies during the current COVID-19 pandemic. Most of these studies …

Definition Coronaviruses are a large group of RNA viruses, the most notable representatives
of which are SARS-CoV, MERS-CoV and SARS-CoV-2. Human coronavirus infections were …

The combination of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2)
infection and other respiratory pathogens is a real challenge for health care systems in terms …

The emerging of the COVID-19 pandemic is currently challenging for the public health
system globally. Beyond SARS-CoV-2 pathogenicity, co-infections with recycling respiratory …

Coagulopathy, cytokine release, platelet hyperactivity and endothelial activation are
regarded as potential major contributors to COVID-19 morbidity. Complement activation …

Objectives: To investigate the seroprevalence of the community-acquired bacterial that
causes atypical pneumonia among confirmed severe acute respiratory syndrome …

The spread of COVID-19 caused by SARS-CoV-2 leads to global emergent health crisis and
has a major impact on medical capacity. Novel drugs and therapeutic strategies are being …

This patent describes the synthesis of compounds, methods, and compositions for
preventing, treating, and/or curing Covid-19, human coronavirus, and enterovirus infections …

Abstract Since December 2019, the COVID-19 virus has rapidly spread worldwide,
prompting the World Health Organization (WHO) to declare it a pandemic and advocate for …